The manufacturer became aware of a rep dreamstation auto bipap device alleging symptoms of nose irritation, respiratory tract irritation, dizziness and/or headache, hypersensitivity, asthma (new or worsening), inflammatory response, lung disease, reduced cardiopulmonary reserve.Medical intervention was not specified by the patient.Due to potential litigation surrounding this case, no follow-up can be performed at this time.At this time, no further investigation can be performed.If any additional information is received a follow-up report will be filed.
|